Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
FDA didn’t publish any new medical device guidance documents for four straight months, but activity has picked up markedly since late May, signaling that the agency’s staff has figured out a path through “deregulatory” directives.
We present selected private financings for May and June, including Alpheus Medical's over-subscribed $50 million Series B round to support its randomized controlled clinical trial on its novel sonodynamic therapy for glioblastoma. Plus a snapshot of our featured cancer impact investor, ACS BrightEdge.
FDA releases performance data. Excerpted from Pathways’ Picks June 18: EU Software Guides, UK Postmarket Law, Stats from Notified Bodies and FDA.